Zevra Therapeutics, Inc. Notes Issued
Zevra Therapeutics, Inc. (ZVRA) reported Notes Issued of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2025-03-12
- Zevra Therapeutics, Inc. notes issued for the quarter ending 2023-12-31 was -$7.00K.
- Zevra Therapeutics, Inc. notes issued for the quarter ending 2022-12-31 was $0.00.
- Zevra Therapeutics, Inc. notes issued for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Zevra Therapeutics, Inc. notes issued for fiscal 2023 was $5.07M.
- Zevra Therapeutics, Inc. notes issued for fiscal 2022 was $0.00.
| Period end | Notes Issued 3 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-12 | ||
| 2023-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $5.07M 10-K · filed 2025-03-12 | |
| 2023-09-30 | $5.07M 10-Q · filed 2023-11-07 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |